Vision-based DMS can only detect impairment, not BAC

In the final post in our three-part series about alcohol impairment, we argue that vision-based driver monitoring systems (DMSs) can accurately detect driver impairment, but not BAC. 

Blood alcohol concentration (BAC) is the prevailing metric to classify a driver as unfit to drive. However, our research shows that impairment persists long after BAC declines, as outlined in the first article in this series. When we say “impairment”, we refer to the increased likelihood of a person making a mistake while driving by not reacting when they should.

Figure 1. On average, participants’ impairment peaks 3.5 hours after their BAC peaks. In summary, BAC is a leading indicator that results in impairment for hours to come.

On the back of our research to understand how impairment arises after an elevated BAC, we also developed an eyelid-based model to detect this impairment, which is covered in greater detail in the second article in this series. In the process of developing this model, our data scientists investigated whether visual inputs could also predict a person’s BAC. 

Unsurprisingly to our team, visual inputs were much better at measuring impairment than BAC. But what continues to surprise us is how many engineering teams are still attempting to build algorithms within a vision-based DMS using BAC as the ground truth. And they repeatedly struggle to achieve good performance as a result. 

This article clarifies why a vision-based DMS is best suited to detecting impairment, but will never achieve high accuracy at measuring BAC. 

A summary of our study on intoxication

Working with the team from KEA Technologies in Boston, we conducted a comprehensive study on how impairment develops after alcohol consumption. The BAC and psychomotor impairment of 30 diverse participants were monitored over a 5 to 8-hour period after drinking alcohol. We found that while BAC peaks early and decreases linearly afterwards, impairment continues to increase for hours. In other words, drivers can be severely impaired for hours even when under the legal limit for BAC. 

To develop our model, we needed visual data of the participants as they performed the vigilance tests. They were recorded using two cameras in the following locations:

    • Centre location – dashboard driver monitoring system (DMS)
    • Top right location – rear-view mirror occupant monitoring system (OMS)
We derived eyelid signals from these videos to develop our impairment detection algorithm.

Why can a DMS detect impairment accurately, but not BAC?

To answer this question, let us revisit the definitions of the two metrics, how they interact, and how they are expressed physiologically.

BAC
Impairment
What is it?
Amount of alcohol in blood
Increase in risk of driver error
How is it measured?
Gold standard: Blood
Very accurate: Breath
Laboratory: EOO in JTV
On-track: Two wheels out of lane twice within 15 minutes
What DMS sensors can measure it and how?
Breath-based sensors
Possibly touch-based sensors (via visible capillaries in the fingers)
Best detected with: Image-based sensors observing eye and eyelid coordination, as well as head and face movements
What countermeasures may reduce risk?
Time
Cool air, haptic feedback, audible alerts, ADAS countermeasures
Trefor Morgan headshot

Dr. Trefor Morgan, General Manager R&D, Optalert
Optalert’s General Manager of Research and Development, Dr. Trefor Morgan, summarises as follows:
“Psychomotor impairment can persist for hours after an elevated BAC. This impairment presents as a reduction in coordination of physical movements. Vision-based driver monitoring systems see the subtle changes in a person’s movements, not the level of alcohol in the blood. Accordingly, these systems will always detect impairment far more effectively than BAC.”

So, what does this all mean?
Vision-based DMS is the ground truth to accurately measure impairment and accelerate driver safety

Optalert’s research reveals that drivers with BAC levels below the legal limit can still be impaired enough to pose a risk on the road. This has profound implications for road safety, and highlights the need to detect impairment as a separate metric than BAC.

This is why we have developed an algorithm based on eyelid movements to monitor impairment in real-time.

By monitoring eyelid movements via a vision-based DMS, we can accurately detect driver impairment and enact countermeasures.

In such a scenario, there are possible countermeasures to restimulate the driver including:

  • Increasing airflow; or
  • Initiating haptic or audible feedback to alert the driver they are impaired, and encouraging them to rest and recuperate.

The advanced driver assistance system (ADAS) can also intervene in a number of ways to reduce the immediate risk from an impaired driver:

  • Adaptive cruise control (ACC) could increase the distance from the vehicle in front.
  • Lane-keeping assistance (LKA) could increase interventions.
  • Automatic emergency braking (AEB) could increase sensitivity.
  • The vehicle could prevent the driver from exceeding the speed limit.

The most effective countermeasures remain an active area for further research.

But there is strong evidence that vision-based DMS is best suited for identifying impairment, while BAC measurement should remain the domain of breath and touch-based sensors. Consequently, any algorithm that sits within a vision-based DMS should be both developed and validated against the ground truth of impairment:

  • Errors of omission (EOO) in a laboratory-based test; and
  • Two wheels out lane twice within 15 minutes (WOOL 2×15) in an on-track test.
optalert eyelid technology that detects impairment via eye blinks

Detect impairment in real-time

Optalert has developed the most accurate impairment detection algorithm due to alcohol. This will revolutionise road safety by accurately identifying impairment in real-time. 

With solutions grounded in rigorous research and cutting-edge technology, Optalert’s products provide a proactive approach to driver safety – going beyond traditional approaches to address true fitness to drive based on objective biomarkers. 

Contact us today to learn more about our innovative DMS solutions and how we are shaping the future of driver monitoring.